Dear NYS COVID-19 Vaccine Provider:
On January 4, 2022, the CDC updated the recommendation for receipt of a booster dose of the COVID-19 vaccine following receipt of the Pfizer-BioNTech primary series. CDC now recommends receipt of a booster dose at least five months after completing their Pfizer-BioNTech primary series. This previously refcommended interval was at least six months.
On January 3 and 4, 2022, the FDA amended the EUA and CDC updated recommendations such that moderately to severely immunocompromised 5-11 year-olds receive an additional primary dose of vaccine 28 days after their second dose. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for children ages 5-11.
On January 5, 2022, the CDC endorsed the Advisory Committee on Immunization Practice’s (ACIP) recommended expansion of booster dose eligibility for the Pfizer-BioNTech COVID-19 to individuals ages 12 to 15. CDC now recommends that all adolescents ages 12 to 17 should receive a booster dose five months after their initial Pfizer-BioNtech vaccination series.
Attached are updated guidance documents, consent forms, and screening checklists:
Thank you for your ongoing participation in the COVID-19 Vaccination Program.
The NYS COVID-19 Vaccine Team